Citius Oncology Inc (NASDAQ: CTOR) is -86.18% lower on its value in year-to-date trading and has touched a low of $0.55 and a high of $49.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CTOR stock was last observed hovering at around $1.54 in the last trading session, with the day’s gains setting it 0.03%.
Currently trading at $1.57, the stock is -52.45% and -18.15% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 16.13 million and changing 1.95% at the moment leaves the stock 24.13% off its SMA200. CTOR registered 36.52% gain for a year compared to 6-month gain of 42.73%. The firm has a 50-day simple moving average (SMA 50) of $1.89218 and a 200-day simple moving average (SMA200) of $1.265215.
The stock witnessed a 6.80% loss in the last 1 month and extending the period to 3 months gives it a 136.52%, and is -63.82% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 34.78% over the week and 31.41% over the month.
Fwd P/E is 31.40. Distance from 52-week low is 185.14% and -96.80% from its 52-week high. The company has generated returns on investments over the last 12 months (-52.88%).
The EPS is expected to shrink by -54.84% this year
9.0 institutions hold shares in Citius Oncology Inc (CTOR), with institutional investors hold 15.38% of the company’s shares. The shares outstanding are 71.55M, and float is at 3.52M with Short Float at 10.40%. Institutions hold 0.76% of the Float.
